intrarosa
endoceutics s.a. - prasteron - postmenopauze - andere geslachtshormonen en modulatoren van het genitale systeem - intrarosa is geïndiceerd voor de behandeling van vulvaire en vaginale atrofie bij postmenopauzale vrouwen met matige tot ernstige symptomen.
abiraterone accord
accord healthcare s.l.u. - abirateronacetaat - prostaatnoplasma - endocriene therapie - abiraterone accord is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt)the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicatedthe treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel based chemotherapy regimen.
abiraterone krka
krka, d.d., novo mesto - abirateronacetaat - prostaatnoplasma - endocriene therapie - abiraterone krka is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt) (see section 5. 1)the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated (see section 5. 1)the treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel-based chemotherapy regimen.
abiraterone mylan
mylan ireland limited - abirateronacetaat - prostaatnoplasma - endocrine therapy, other hormone antagonists and related agents - abiraterone mylan is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt). the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated. the treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel based chemotherapy regimen.
progesteron besins 100 mg zachte caps.
besins healthcare sa-nv - progesteron 100 mg - capsule, zacht - 100 mg - progesteron 100 mg - progesterone
progesteron besins 200 mg zachte caps.
besins healthcare sa-nv - progesteron 200 mg - capsule, zacht - 200 mg - progesteron 200 mg - progesterone
amelgen 400 mg ovule
gedeon richter plc - progesteron 400 mg - ovule - 400 mg - progesteron 400 mg - progesterone
utrogestan vaginal 300 mg zachte caps.
besins healthcare sa-nv - progesteron 300 mg - capsule, zacht - 300 mg - progesteron 300 mg - progesterone
abirateron eg 250 mg filmomh. tabl.
eg sa-nv - abirateronacetaat 250 mg - filmomhulde tablet - 250 mg - abirateronacetaat 250 mg - abiraterone
abirateron eg 500 mg filmomh. tabl.
eg sa-nv - abirateronacetaat 500 mg - filmomhulde tablet - 500 mg - abirateronacetaat 500 mg - abiraterone